Chimeric Therapeutics Limited (CHMMF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 20.71 Million AUD | -29.75% |
| 2023 | 29.48 Million AUD | 71.54% |
| 2022 | 17.18 Million AUD | 9.55% |
| 2021 | 15.69 Million AUD | 24414.53% |
| 2020 | 64 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.72 Million AUD | 109.87% |
| 2024 Q4 | 16.77 Million AUD | 0.0% |
| 2024 Q1 | 4.15 Million AUD | -71.96% |
| 2024 FY | 20.71 Million AUD | -29.75% |
| 2023 Q1 | 7.32 Million AUD | -6.57% |
| 2023 FY | 29.48 Million AUD | 71.54% |
| 2023 Q4 | 14.82 Million AUD | 99.84% |
| 2023 Q3 | 7.42 Million AUD | -49.38% |
| 2023 Q2 | 14.65 Million AUD | 100.0% |
| 2022 Q4 | 7.84 Million AUD | 91.77% |
| 2022 FY | 17.18 Million AUD | 9.55% |
| 2022 Q3 | 4.09 Million AUD | -56.23% |
| 2022 Q2 | 9.34 Million AUD | 95.84% |
| 2022 Q1 | 4.77 Million AUD | -57.79% |
| 2021 Q2 | 3.54 Million AUD | 96.64% |
| 2021 FY | 15.69 Million AUD | 24414.53% |
| 2021 Q4 | 11.3 Million AUD | 96.53% |
| 2021 Q3 | 5.75 Million AUD | 62.36% |
| 2021 Q1 | 1.8 Million AUD | 0.0% |
| 2020 FY | 64 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -1300.862% |
| CSL Limited | 3.44 Billion USD | 99.399% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 76.13% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -321.221% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -7814.871% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 29.905% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 44.397% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -1279.272% |
| Mesoblast Limited | 5.9 Million USD | -250.987% |
| Marizyme, Inc. | 19.23 Million USD | -7.669% |
| Genus plc | 147.7 Million USD | 85.975% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -135.958% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -1444.136% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -148.414% |
| ContraFect Corporation | 56.88 Million USD | 63.587% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -369.876% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 37.7 Million USD | 45.066% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -642.388% |
| MultiCell Technologies, Inc. | 567.42 USD | -3650683.194% |
| Accustem Sciences Inc. | 3.74 Million USD | -452.935% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 75.897% |
| EV Biologics, Inc. | 531.96 Thousand USD | -3794.127% |
| Q BioMed Inc. | 3.43 Million USD | -502.779% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 16.183% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -688.396% |
| Biomind Labs Inc. | 994.18 Thousand USD | -1983.65% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -208.354% |
| Skye Bioscience, Inc. | 13.54 Million USD | -52.908% |
| SQZ Biotechnologies Company | 85.61 Million USD | 75.805% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 82961.096% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -310.851% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -610.343% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -29.388% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -5217.526% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 90.813% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -911.14% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -1028.839% |
| GB Sciences, Inc. | 1.42 Million USD | -1358.299% |
| Alpha Cognition Inc. | 9.7 Million USD | -113.436% |
| argenx SE | 1.53 Billion USD | 98.649% |
| HST Global, Inc. | 140.9 Thousand USD | -14601.38% |
| Halberd Corporation | 74.84 Thousand USD | -27578.675% |
| Enzolytics Inc. | 2.17 Million USD | -850.457% |
| Resverlogix Corp. | 12.71 Million USD | -62.958% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -467.432% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 63.936% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 79.145% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -1884.222% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -1077.22% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -761.366% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -1011.114% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -1211.629% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -508.382% |
| AVAX Technologies, Inc. | 7.31 Million USD | -183.372% |
| ONE Bio Corp. | 6.44 Million USD | -221.471% |
| Zenith Capital Corp. | 8.94 Million USD | -131.637% |
| Genscript Biotech Corporation | 825.34 Million USD | 97.49% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -118809.787% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -743.69% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -11978.243% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -978.412% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -1741.505% |
| Agentix Corp. | 1.37 Million USD | -1410.128% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 2.41 Million USD | -759.515% |
| Helix BioMedix, Inc. | 1.97 Million USD | -950.452% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -90.626% |
| BioStem Technologies, Inc. | 22.97 Million USD | 9.835% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -11314.317% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -1451.205% |
| LadRx Corporation | 3.81 Million USD | -443.453% |
| Cell Source, Inc. | 4.32 Million USD | -378.928% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -4885.878% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -2143.102% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -2143.102% |
| NovAccess Global Inc. | 2.46 Million USD | -739.776% |
| Affymax, Inc. | 39.38 Million USD | 47.404% |
| Itoco Inc. | 919.14 Thousand USD | -2153.76% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -388.751% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -1751.231% |
| CytoDyn Inc. | 18.05 Million USD | -14.715% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -82204.716% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -9312.696% |
| Qrons Inc. | 643.67 Thousand USD | -3118.272% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -1359.036% |
| SYBLEU INC | 160.87 Thousand USD | -12776.547% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -828.986% |
| Rebus Holdings, Inc. | 664 Thousand USD | -3019.77% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -1040.508% |
| Mobile Lads Corp. | 554.54 Thousand USD | -3635.538% |
| International Stem Cell Corporation | 5.27 Million USD | -293.005% |
| Bioxytran, Inc. | 3.82 Million USD | -442.264% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -39251.229% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -101729.986% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 42.88% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -1180.301% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -2715.206% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -565.872% |
| Neutra Corp. | 243.82 Thousand USD | -8396.099% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -18.665% |
| PureTech Health plc | 144.59 Million USD | 85.674% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -1.1% |
| IXICO plc | 4.7 Million USD | -340.095% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -135.481% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 82.407% |
| CSL Limited | 3.89 Billion USD | 99.468% |
| Cellectis S.A. | 97.32 Million USD | 78.714% |